EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.1.1.348 | Alzheimer Disease |
32847866 |
Altered Expression of the m6A Methyltransferase METTL3 in Alzheimer's Disease. |
causal interaction
diagnostic usage
ongoing research
unassigned |
3
3
1
0 |
| 2.1.1.348 | Aortic Aneurysm, Abdominal |
32650237 |
METTL3 Induces AAA Development and Progression by Modulating N6-Methyladenosine-Dependent Primary miR34a Processing. |
causal interaction
unassigned |
2
0 |
| 2.1.1.348 | Aortic Valve Stenosis |
31761339 |
Factors influencing osteogenic differentiation of human aortic valve interstitial cells. |
diagnostic usage
ongoing research
unassigned |
1
3
0 |
| 2.1.1.348 | Arthritis, Rheumatoid |
31772500 |
METTL3 Attenuates LPS-Induced Inflammatory Response in Macrophages via NF-?B Signaling Pathway. |
causal interaction
unassigned |
3
0 |
| 2.1.1.348 | Arthritis, Rheumatoid |
32884942 |
Decreased ALKBH5, FTO, and YTHDF2 in Peripheral Blood Are as Risk Factors for Rheumatoid Arthritis. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
2
4
1
0 |
| 2.1.1.348 | Arthritis, Rheumatoid |
34295905 |
METTL3 Promotes Activation and Inflammation of FLSs Through the NF-?B Signaling Pathway in Rheumatoid Arthritis. |
causal interaction
unassigned |
4
0 |
| 2.1.1.348 | Asthenozoospermia |
27072590 |
Increased N6-methyladenosine in Human Sperm RNA as a Risk Factor for Asthenozoospermia. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
4
1
0 |
| 2.1.1.348 | Atherosclerosis |
32802173 |
METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications. |
causal interaction
ongoing research
therapeutic application
unassigned |
4
4
4
0 |
| 2.1.1.348 | Atherosclerosis |
33301833 |
METTL14 mediated m6A modification to LncRNA ZFAS1/ RAB22A: A novel therapeutic target for atherosclerosis. |
therapeutic application
unassigned |
3
0 |
| 2.1.1.348 | Atherosclerosis |
33579825 |
METTL3-dependent N6-methyladenosine RNA modification mediates the atherogenic inflammatory cascades in vascular endothelium. |
ongoing research
unassigned |
1
0 |
